Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
The MSL Career Ladder…What options are available and how to position yourself for advancement with Davida White
Summary
In this episode, Davida White shares her insights on the evolving landscape of Medical Science Liaison roles and medical affairs. She discusses her career journey and emphasizes the importance of growth opportunities, particularly through medical support roles. Davida highlights the significance of taking initiative, prioritizing experience over job titles, and setting career goals with leadership. She also delves into the role of mentorship and networking in career advancement. The conversation touches on adapting to post-COVID-19 changes and the strategic value of lateral career moves. The episode concludes with Davida's thoughts on summertime plans.
My guest today is Davida White, US Oncology Field Medical Alignment Director at Merck and we discuss the MSL Career Ladder and what career options are available to MSLs as well as how to position yourself for promotion.
In this episode:
- Davida’s background and her work now
- Her journey and transition to the industry
- What options are available past the title or the role of an MSL
- Pursuing some of these career options for MSLs
- Management development programs
- Her take on mentors and mentorship type programs
- Skills to be developed for MSLs to advance their careers
- Advice for people to help them get noticed and what steps should be taken
Medical Science Liaison, career advancement, mentorship and networking, strategic career moves, MSL career ladder
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO